3Hondt JL. Strategy for the screening of tetrahydrobioptein deficiency among hyperphenylalaninemic patients: 15-year experience. J Inher Metab Dis, 1991, (14): 117-127.
二级参考文献14
1Millington DS;Kodo N;Norwood DL.Tandem mass spectrometry:a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism[J],1990.
2Chace DH;Kalas TA;Naylor.The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism[J],2002(0).
3Zytkovicz TH;Fitzgerald EF;Marsden D.Tandem mass spectrometry analysis for amino,organic,and fatty acid disorders in newborn dried blood spots:a two-year summary from the New England newborn screening program,2001.
4WILEY V;Carpenter K, Wilcken.Newborn Screening with tandem mass spectrometry:12 months experience in NSW Australia,1999.
5Jones PM;Bennett MJ.The changing face of newborn screening:diagnosis of inborn errors of metabolism by tandem mass spectrometry[J],2002.
6Levy HL.Newborn screening by tandem mass spectrometry:a new era,1998.
7Shigematsu Y;Hirano S;Hata I.Newborn mass screening and selective screening using elctrospray tandem mass spectrometry in Japan[J],2002(1).
8Schoen EJ;Baker JC;Colby CJ.Cost-benefit analysis of universal tandem mass spectrometry for newborn screening[J],2002.
9Insinga RP;Laessig RH;Hoffman GL.Newborn screening with tandem mass spectrometry:examining its cost-effectiveness in the Wisconsin newborn screening panel[J],2002.
10S. E. Snyderman,C. Sansaricq,M. T. Pulmones. Successful long term therapy of biopterin deficiency[J] 1987,Journal of Inherited Metabolic Disease(3):260～266
